ODT
Odonate Therapeutics, Inc.
Director and 10% owner Aaron I. Davis bought $395K of Odonate Therapeutics, Inc.
Bought$394,753
$14.72Price
26,824Shares
+1%Stake
What ODT did for a copier
Prices for ODT after this filing aren't in yet.
Aaron I. Davis's record
6 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Oct 24. Filed Fri, Oct 26, 12:32 PM ET, during the session. Not investment advice.